These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14662895)

  • 21. Disease-related autoantibody profile in patients with systemic sclerosis.
    Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
    Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
    Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody against a protease domain of caspase-8 in patients with systemic sclerosis.
    Yamaoka T; Ogawa F; Muroi E; Hara T; Komura K; Iwata Y; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Clin Exp Rheumatol; 2008; 26(6):998-1004. PubMed ID: 19210862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.
    Wermuth PJ; Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):21-30. PubMed ID: 28094758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.
    Ronda N; Gatti R; Giacosa R; Raschi E; Testoni C; Meroni PL; Buzio C; Orlandini G
    Arthritis Rheum; 2002 Jun; 46(6):1595-601. PubMed ID: 12115191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
    Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
    Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y
    Clin Exp Immunol; 1994 Sep; 97(3):445-50. PubMed ID: 8082299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
    Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
    Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
    Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
    Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis.
    Khan L; Derksen T; Redmond D; Storek J; Durand C; Gniadecki R; Korman B; Cohen Tervaert JW; D'Aubeterre A; Osman MS; Willis LM
    J Autoimmun; 2023 Nov; 140():103110. PubMed ID: 37742510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.
    Fineschi S; Goffin L; Rezzonico R; Cozzi F; Dayer JM; Meroni PL; Chizzolini C
    Arthritis Rheum; 2008 Dec; 58(12):3913-23. PubMed ID: 19035500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.
    Kawaguchi Y; Suzuki K; Hara M; Hidaka T; Ishizuka T; Kawagoe M; Nakamura H
    Ann Rheum Dis; 1994 Aug; 53(8):506-10. PubMed ID: 7944634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Aquaporin3 in Systemic Sclerosis Dermal Fibroblasts.
    Yousefi B; Mahmoudi M; Sarafnejad A; Karimizadeh E; Farhadi E; Jamshidi AR; Kavosi H; Aslani S; Gharibdoost F
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):228-234. PubMed ID: 28732436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.